First human trial launches for experimental PSTB100 drug
Knowledge-focused
Not yet recruiting
This first-in-human study tests the safety and tolerability of PSTB100 tablets in healthy adults aged 18 to 55. Participants receive either a single or multiple doses of the drug or a placebo. Researchers measure how the body absorbs, processes, and eliminates PSTB100 to guide fu…
Phase: PHASE1 • Sponsor: Prospect Therapeutics (Nanjing) Limited • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC